Bispecific antibody research and development among China, the United States and Europe
Bispecific antibodies (BiAbs), which can simultaneously bind two distinct antigens, have emerged as a promising therapeutic strategy for treating cancer, autoimmune disorders, and metabolic diseases. The United States, China, and Europe are the leadin
Authors
- Jinli Huang (ORCID: https://orcid.org/0000-0002-6912-1885)
- Yuxuan Gong (ORCID: https://orcid.org/0000-0001-5735-6508)
- Sirong He
- Dan Wang (ORCID: https://orcid.org/0000-0003-4186-3796)
- Xiaotong Yang
- Zetong Wu
Institutions
- University of Leicester (GB)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Published
- 2025-08-21
- DOI
- https://doi.org/10.22541/au.175576332.25254096/v1
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00